
WIB22: She reshaped migraine science and led key trials for new drugs, but Sheena Aurora isn’t done
This profile is part of Endpoints News’ 2022 special report about Women in Biopharma R&D. You can read the full report here.
For decades — even centuries — migraines were considered a disorder suffered by hysterical women.
Even when the father of modern-day migraine research pioneered a new understanding of migraine as a biological phenomenon having to do with blood vessels, he focused on explaining the condition for men but described women migraine sufferers, who make up the vast majority of the patient population, as inadequate wives and mothers.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters